Clinical Trials Directory

Trials / Completed

CompletedNCT01106911

Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment

Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment: a Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,080 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
Female
Age
35 Years – 55 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is that DBT in combination with FFDM will reduce baseline screening mammography recall rates in negative examinations by at least 20%.

Detailed description

The FFDM images and the FFDM images with the DBT images will be interpreted independently by two experienced radiologists under standard clinical screening procedures. Recommended recall rates will be assessed and compared as a result of each of the two interpretations.

Conditions

Interventions

TypeNameDescription
DEVICEtomosynthesis and screening mammographyAll eligible subjects will undergo both full field digital mammography and digital breast tomosynthesis.

Timeline

Start date
2010-05-01
Primary completion
2014-09-01
First posted
2010-04-20
Last updated
2016-03-25
Results posted
2016-03-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01106911. Inclusion in this directory is not an endorsement.